ISPOR - EE478 A Budget Impact Analysis of Introducing Filgotinib as a First-Line Treatment for Moderate to Severe Ulcerative Colitis in Greece

Full Text

EE478 A Budget Impact Analysis of Introducing Filgotinib as a First-Line Treatment for Moderate to Severe Ulcerative Colitis in Greece

Abstract

Authors

N Nomikos P Naoum K Athanasakis I Kyriopoulos

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now